JP2006502219A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502219A5
JP2006502219A5 JP2004543136A JP2004543136A JP2006502219A5 JP 2006502219 A5 JP2006502219 A5 JP 2006502219A5 JP 2004543136 A JP2004543136 A JP 2004543136A JP 2004543136 A JP2004543136 A JP 2004543136A JP 2006502219 A5 JP2006502219 A5 JP 2006502219A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004543136A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502219A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/031413 external-priority patent/WO2004032840A2/en
Publication of JP2006502219A publication Critical patent/JP2006502219A/ja
Publication of JP2006502219A5 publication Critical patent/JP2006502219A5/ja
Pending legal-status Critical Current

Links

JP2004543136A 2002-10-11 2003-10-02 化合物、組成物および方法 Pending JP2006502219A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41788902P 2002-10-11 2002-10-11
PCT/US2003/031413 WO2004032840A2 (en) 2002-10-11 2003-10-02 Compounds, compositions, and methods

Publications (2)

Publication Number Publication Date
JP2006502219A JP2006502219A (ja) 2006-01-19
JP2006502219A5 true JP2006502219A5 (cg-RX-API-DMAC7.html) 2006-11-02

Family

ID=32094113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004543136A Pending JP2006502219A (ja) 2002-10-11 2003-10-02 化合物、組成物および方法

Country Status (19)

Country Link
US (1) US7476743B2 (cg-RX-API-DMAC7.html)
EP (1) EP1558588A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006502219A (cg-RX-API-DMAC7.html)
KR (1) KR20050075356A (cg-RX-API-DMAC7.html)
CN (1) CN1726198A (cg-RX-API-DMAC7.html)
AR (1) AR044193A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003282665A1 (cg-RX-API-DMAC7.html)
BR (1) BR0315247A (cg-RX-API-DMAC7.html)
CA (1) CA2501938A1 (cg-RX-API-DMAC7.html)
IL (1) IL167936A0 (cg-RX-API-DMAC7.html)
IS (1) IS7798A (cg-RX-API-DMAC7.html)
MX (1) MXPA05003830A (cg-RX-API-DMAC7.html)
NO (1) NO20052267L (cg-RX-API-DMAC7.html)
NZ (1) NZ539643A (cg-RX-API-DMAC7.html)
PL (1) PL375889A1 (cg-RX-API-DMAC7.html)
RU (1) RU2005114491A (cg-RX-API-DMAC7.html)
TW (1) TW200418818A (cg-RX-API-DMAC7.html)
WO (1) WO2004032840A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200503733B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06014909A (es) * 2004-06-18 2007-02-28 Chiron Corp Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer.
CN101027309B (zh) 2004-08-18 2010-10-27 阿斯利康(瑞典)有限公司 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途
DE102006023337A1 (de) * 2006-05-18 2007-11-22 Merck Patent Gmbh Triazolderivate II
JP5343363B2 (ja) * 2008-01-31 2013-11-13 アイシン精機株式会社 シートクッション調整装置
CN101643451B (zh) * 2008-08-07 2013-03-06 浙江海正药业股份有限公司 过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
EP2558450A1 (en) 2010-04-15 2013-02-20 Novartis AG Triazole compounds as ksp inhibitors
WO2012095691A1 (en) * 2011-01-15 2012-07-19 Jubilant Life Sciences Ltd. An improved process for producing aminopyridines
WO2013134562A1 (en) 2012-03-09 2013-09-12 Inception 2, Inc. Triazolone compounds and uses thereof
MX376108B (es) 2012-12-20 2025-03-07 Tempest Therapeutics Inc Compuestos de triazolona y usos de los mismos.
AU2014315151A1 (en) 2013-09-06 2016-03-03 Inception 2, Inc. Triazolone compounds and uses thereof
SG11201710639YA (en) * 2015-06-22 2018-01-30 Bayer Pharma AG Antibody drug conjugates (adcs) and antibody prodrug conjugates (apdcs) with enzymatically cleavable groups
TW201722958A (zh) * 2015-09-15 2017-07-01 葛蘭素史克智慧財產(第二)有限公司 化學化合物
AU2017380871C1 (en) 2016-12-21 2025-05-15 Bayer Aktiengesellschaft Antibody drug conjugates (ADCs) having enzymatically cleavable groups
WO2023192499A1 (en) * 2022-03-30 2023-10-05 Primefour Therapeutics, Inc. Nucleosides for treating cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793532A (fr) * 1971-12-29 1973-06-29 Upjohn Co Nouvelles 1,2,4-triazol-3-ones et leur preparation
US3748339A (en) 1972-05-05 1973-07-24 Upjohn Co 2-(3-(1-(dimethylamino)alkyl)-1,5-dihydro-5-oxo - 1 - substituted-4h-1,2,4-triazol-4-yl)benzophenone and process
NO773853L (no) 1976-11-17 1978-05-19 Montedison Spa Nye fosforsyreestre avledet fra 1,2,4-triazol med insekticid, nematocid og acaricid virkning, og fremstilling av disse
IT1068010B (it) * 1976-11-17 1985-03-21 Montedison Spa Nuovi esteri fosforici derivati dall' 1-2-4 triazolo ad azione insetticida,nematocida e acaricida e loro preparazione
US4487773A (en) 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US5250558A (en) * 1992-01-28 1993-10-05 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
GB9211193D0 (en) * 1992-05-27 1992-07-08 Merck Sharp & Dohme Therapeutic agents
CA2099233A1 (en) * 1992-06-29 1993-12-30 Conrad P. Dorn Morpholine and thiomorpholine tachykinin receptor antagonists
WO1997014671A1 (en) * 1995-10-18 1997-04-24 Merck & Co., Inc. Cyclopentyl tachykinin receptor antagonists
JP2002234874A (ja) * 2000-09-26 2002-08-23 Tanabe Seiyaku Co Ltd 5−フェニルベンジルアミン誘導体、その製法及びその合成中間体
US6727244B2 (en) * 2000-10-26 2004-04-27 Merck & Co., Inc. Mammalian metabolites of a tachykinin receptor antagonist
IL165624A0 (en) * 2002-06-14 2006-01-15 Merck & Co Inc Mitotic kinesin inhibitors

Similar Documents

Publication Publication Date Title
RU2005114491A (ru) Соединения, составы и способы их использования
JP2006514689A5 (ja) 1−オキソ−2−(2,6−ジオキソピペリジン−3−イル)−4−メチルイソインドリンを含む脳腫瘍の治療及び管理のための医薬組成物
JP2005536475A5 (cg-RX-API-DMAC7.html)
CA2409741A1 (en) Tnf-.alpha. production inhibitors
JP2003525279A5 (cg-RX-API-DMAC7.html)
RU2000117278A (ru) Производное 2-арил-8-оксодигидропурина, способ для его получения, содержащая его фармацевтическая композиция, и промежуточное соединение
JP2005523312A5 (cg-RX-API-DMAC7.html)
JP2002501049A5 (cg-RX-API-DMAC7.html)
JP2008528469A5 (cg-RX-API-DMAC7.html)
CA2511307A1 (en) Viral polymerase inhibitors
RU2007134380A (ru) Антибактериальные производные пиперидина
US20150051234A1 (en) Therapy for complications of diabetes
JP2005538072A5 (cg-RX-API-DMAC7.html)
JP2008509187A5 (cg-RX-API-DMAC7.html)
DK1682178T3 (da) Fremgangsmåder til terapi af cancere der udtrykker CD-40-antigenet
JP2004504404A5 (cg-RX-API-DMAC7.html)
JP2010507639A5 (cg-RX-API-DMAC7.html)
JP2002523400A5 (cg-RX-API-DMAC7.html)
RU2004133325A (ru) Соединения, композиции на их основе и способы их использования
JP2005533119A5 (cg-RX-API-DMAC7.html)
JP2005538111A5 (cg-RX-API-DMAC7.html)
JP2008534558A5 (cg-RX-API-DMAC7.html)
RU2005131014A (ru) Азотосодержащие гетероциклические производные, содержащие 2, 6-дизамещенный стирил
JP2005503382A5 (cg-RX-API-DMAC7.html)
JP2005539062A5 (cg-RX-API-DMAC7.html)